MSR1 is not required for obesity-associated inflammation and insulin resistance in mice

被引:0
作者
Nance, Sierra A. [1 ,2 ]
Muir, Lindsey [3 ]
Delproprosto, Jennifer [2 ]
Lumeng, Carey N. [1 ,2 ]
机构
[1] Univ Michigan, Mol & Integrat Physiol, Med Sch, 109 Zina Pitcher Pl,2057 BSRB, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Pediat, Med Sch, 109 Zina Pitcher Pl,2057 BSRB, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Computat Med & Bioinformat, Med Sch, Ann Arbor, MI USA
基金
美国国家卫生研究院;
关键词
ADIPOSE-TISSUE; LOCAL PROLIFERATION; INTERLEUKIN-6; PROTECTION; ALPHA;
D O I
10.1038/s41598-023-29736-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Obesity induces a chronic inflammatory state associated with changes in adipose tissue macrophages (ATMs). Macrophage scavenger receptor 1 (MSR1) has been implicated in the regulation of adipose tissue inflammation and diabetes pathogenesis; however, reports have been mixed on the contribution of MSR1 in obesity and glucose intolerance. We observed increased MSR1 expression in VAT of obese diabetic individuals compared to non-diabetic and single nuclear RNA sequencing identified macrophage-specific expression of MSR1 in human adipose tissue. We examined male Msr1(-/-) (Msr1KO) and WT controls and observed protection from obesity and AT inflammation in non-littermate Msr1KO mice. We then evaluated obese littermate Msr1(+/-) (Msr1HET) and Msr1KO mice. Both Msr1KO mice and Msr1HET mice became obese and insulin resistant when compared to their normal chow diet counterparts, but there was no Msr1-dependent difference in body weight, glucose metabolism, or insulin resistance. Flow cytometry revealed no significant differences between genotypes in ATM subtypes or proliferation in male and female mice. We observed increased frequency of proliferating ATMs in obese female compared to male mice. Overall, we conclude that while MSR1 is a biomarker of diabetes status in human adipose tissue, in mice Msr1 is not required for obesity-associated insulin resistance or ATM accumulation.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Latent Inflammation and Defect in Adipocyte Renewal as a Mechanism of Obesity-Associated Insulin Resistance
    Vorotnikov, A. V.
    Stafeev, I. S.
    Menshikov, M. Yu.
    Shestakova, M. V.
    Parfyonova, Ye. V.
    BIOCHEMISTRY-MOSCOW, 2019, 84 (11) : 1329 - 1345
  • [2] A role for 5-lipoxygenase products in obesity-associated inflammation and insulin resistance
    Neels, Jaap G.
    ADIPOCYTE, 2013, 2 (04) : 262 - 265
  • [3] Latent Inflammation and Defect in Adipocyte Renewal as a Mechanism of Obesity-Associated Insulin Resistance
    A. V. Vorotnikov
    I. S. Stafeev
    M. Yu. Menshikov
    M. V. Shestakova
    Ye. V. Parfyonova
    Biochemistry (Moscow), 2019, 84 : 1329 - 1345
  • [4] Role of adipocytokines in obesity-associated insulin resistance
    Zou, Chenhui
    Shao, Jianhua
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2008, 19 (05) : 277 - 286
  • [5] Independent tissue contributors to obesity-associated insulin resistance
    Kusters, Yvo H. A. M.
    Schalkwijk, Casper G.
    Houben, Alfons J. H. M.
    Kooi, M. Eline
    Lindeboom, Lucas
    't Roodt, Jos Op
    Joris, Peter J.
    Plat, Jogchum
    Mensink, Ronald P.
    Barrett, Eugene J.
    Stehouwer, Coen D. A.
    JCI INSIGHT, 2017, 2 (13):
  • [6] Normalization of obesity-associated insulin resistance through immunotherapy
    Winer, Shawn
    Chan, Yin
    Paltser, Geoffrey
    Truong, Dorothy
    Tsui, Hubert
    Bahrami, Jasmine
    Dorfman, Ruslan
    Wang, Yongqian
    Zielenski, Julian
    Mastronardi, Fabrizio
    Maezawa, Yuko
    Drucker, Daniel J.
    Engleman, Edgar
    Winer, Daniel
    Dosch, H. -Michael
    NATURE MEDICINE, 2009, 15 (08) : 921 - U126
  • [7] Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance
    Wueest, Stephan
    Item, Flurin
    Lucchini, Fabrizio C.
    Challa, Tenagne D.
    Mueller, Werner
    Blueher, Matthias
    Konrad, Daniel
    DIABETES, 2016, 65 (01) : 140 - 148
  • [8] A major role of insulin in promoting obesity-associated adipose tissue inflammation
    Pedersen, David J.
    Guilherme, Adilson
    Danai, Laura V.
    Heyda, Lauren
    Matevossian, Anouch
    Cohen, Jessica
    Nicoloro, Sarah M.
    Straubhaar, Juerg
    Noh, Hye Lim
    Jung, DaeYoung
    Kim, Jason K.
    Czech, Michael P.
    MOLECULAR METABOLISM, 2015, 4 (07): : 507 - 518
  • [9] Blocking Fas-signaling in adipocytes and hepatocytes prevents obesity-associated inflammation, insulin resistance, and hepatosteatosis
    Bae, Sumin
    Ullah, Irfan
    Beloor, Jagadish
    Lim, Jaeyeoung
    Chung, Kunho
    Yi, Yujong
    Kang, Eunhwa
    Yun, Gyeongju
    Rhim, Taiyoun
    Lee, Sang-Kyung
    JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY, 2024, 135 : 434 - 443
  • [10] Tumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance
    Perfield, James W., II
    Lee, Yunkyoung
    Shulman, Gerald I.
    Samuel, Varman T.
    Jurczak, Michael J.
    Chang, Eugene
    Xie, Chen
    Tsichlis, Phillip N.
    Obin, Martin S.
    Greenberg, Andrew S.
    DIABETES, 2011, 60 (04) : 1168 - 1176